InvestorsHub Logo
Followers 482
Posts 30219
Boards Moderated 0
Alias Born 06/15/2007

Re: None

Wednesday, 03/08/2017 10:55:06 AM

Wednesday, March 08, 2017 10:55:06 AM

Post# of 5124
BMGP should move up at some point here IMO.


BMGP~
*Upon completion of clinical trials in Latin America and Asia, the company will initiate a 510K registration with the U.S. Food and Drug Administration (F.D.A).

http://biomagneticsbmgp.com/Grace.pdf

Detects viral infections 3-4 times quicker than any other method
http://trove.nla.gov.au/work/83035468?q=+&versionId=96347871
has two patents other diseases with similar symptoms such as malaria, cholera Those are the two closest disease to EBOLA. We have products for both of them to detect and prevent earlier than anything else

http://www.biomagneticsbmgp.com/technology_partner.html
Technology Partner
Dr. Hai Shiene Chen, M.D., M.S. – President & CEO

Dr. Hai Shiene Chen, was educated at The Second Military Medical University, Shanghai, China. He received his Medical Degree in 1983, graduating in the top 2% of his class. Between 1986 and 1988, Dr. Chen trained at Harvard Medical School in the field of cancer research. In 1990, Dr. Chen obtained a M. Sc. Degree from the University of Toronto, and while there, directed a research project on HIV. From 1991 to 1996, Dr. Chen was a Managing Director for the Canadian Genetic Diseases Network’s Core Facility. In 1995, Dr. Chen founded ACGT Corporation.

Dr. Chen has demonstrated the skill necessary to identify opportunity and initiate an action planning process to achieve results. He has successfully managed a multi-service international operation, and is widely respected in the medical technology community for his efficiency. To date, Dr. Chen is the sole inventor for ACGT’s patents. Dr. Chen has demonstrated the ability to initiate and move an idea forward, and is a key value driver for ACGT.
http://acgtcorp.com/company-people/



PEPSI